Cancer Immunotherapy Market Scope And Analysis

  • Report Code : TIPRE00006688
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dell'immunoterapia contro il cancro e dei suoi concorrenti entro il 2025-2031

Buy Now

Cancer Immunotherapy Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Terapia
  • anticorpi monoclonali
  • inibitori dei checkpoint immunitari
  • modulatori del sistema immunitario
  • vaccini contro il cancro
By Applicazione
  • cancro ai polmoni
  • cancro colorettale
  • cancro al seno
  • cancro alla prostata
  • melanoma
  • cancro alla testa e al collo
  • cancro alle ovaie
By Utente finale
  • ospedali
  • centri chirurgici ambulatoriali
  • centri di ricerca sul cancro
  • cliniche specialistiche
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F. Hoffmann-La Roche AG
  • Advaxis Inc.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Immunomedics Inc.